PALI · ISSUER CIK 1357459
PALISADE BIO, INC.
Between Aug 1, 2026 and Oct 29, 2026, 4 PALISADE BIO, INC. insiders reported $29K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Williams Donald Allen (Director), with $29K.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$29KInsider buying
$0.00Insider selling
+$29KNet open-market
Oct 21, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 202617:44 | Oct 19, 2026 | PALI | See Remarks | A · Grant | — | +787,300 | 787,300 | New | — | ||
| Oct 7, 202621:35 | Oct 6, 2026 | PALI | See Remarks | M · Exercise | — | +2,620,850 | 2,714,859 | +2788% | — | ||
| Oct 7, 202621:35 | Oct 6, 2026 | PALI | See Remarks | F · Tax | $1.49 | −1,031,102 | 1,683,757 | -38% | $1.5M | ||
| Oct 7, 202621:35 | Oct 6, 2026 | PALI | CEO CFO, Director | M · Exercise | — | +3,227,384 | 3,356,672 | +2496% | — | ||
| Oct 7, 202621:35 | Oct 6, 2026 | PALI | CEO CFO, Director | F · Tax | $1.49 | −1,411,982 | 1,944,690 | -42% | $2.1M | ||
| Oct 5, 202617:20 | Oct 2, 2026from Oct 1, 2026 | PALI | Director | P · Buy | $1.44 | +20,000 | 1,590,294 | +1% | +$29K | -34.5% | -17.4% |
| Aug 21, 202618:26 | Aug 19, 2026 | PALI | CEO, CFO, Director | G · Gift | — | −88,400 | 129,288 | -41% | — | ||
| Aug 21, 202618:26 | Aug 19, 2026 | PALI | CEO, CFO, Director | G · Gift | — | +88,400 | 88,451 | +173333% | — |